ImmunoPrecise Antibodies (IPA) Misses Q4 EPS by 5c

ImmunoPrecise Antibodies (NASDAQ: IPA) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $6.98 million.

For earnings history and earnings-related data on ImmunoPrecise Antibodies (IPA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• Crusoe in talks to raise $3B in funding - Bloomberg